Chronic Fatigue Syndrome Latest Advances

Understanding concussion in myalgic encephalomyelitis/chronic fatigue syndrome: Findings from the 2023 National Health Interview study.

Journal: Brain injury

Published: October 17, 2025

First proposed blood test for chronic fatigue syndrome: what scientists think.

Journal: Nature

Published: October 09, 2025

RETRACTION: Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study.

Journal: Food science & nutrition

Published: October 07, 2025

Advancing Digital Precision Medicine for Chronic Fatigue Syndrome through Longitudinal Large-Scale Multi-Modal Biological Omics Modeling with Machine Learning and Artificial Intelligence.

Journal: ArXiv

Published: September 22, 2025

Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment.

Journal: Journal of psychopharmacology (Oxford, England)

Published: September 17, 2025

NOTIFICATION: Chronic Fatigue Syndrome.

Journal: The Medical journal of Australia

Published: September 16, 2025

Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: September 11, 2025

Chronic overlapping pain conditions in individuals with active opioid use disorder: a descriptive study of syringe program participants.

Journal: Journal of addictive diseases

Published: September 03, 2025

Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: August 21, 2025

Protocol for a qualitative study on the online connections of people with ME/CFS and the relationship between these online connections and offline lives.

Journal: BMJ open

Published: August 19, 2025

Co-occurrence of severe fatigue and insomnia: implications for the outcome of cognitive behavioural therapies.

Journal: Behavioural and cognitive psychotherapy

Published: August 18, 2025

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Journal: Journal of translational medicine

Published: August 14, 2025

Filters

Understanding concussion in myalgic encephalomyelitis/chronic fatigue syndrome: Findings from the 2023 National Health Interview study.

Understanding concussion in myalgic encephalomyelitis/chronic fatigue syndrome: Findings from the 2023 National Health Interview study.

First proposed blood test for chronic fatigue syndrome: what scientists think.

First proposed blood test for chronic fatigue syndrome: what scientists think.

RETRACTION: Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study.

RETRACTION: Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study.

Advancing Digital Precision Medicine for Chronic Fatigue Syndrome through Longitudinal Large-Scale Multi-Modal Biological Omics Modeling with Machine Learning and Artificial Intelligence.

Advancing Digital Precision Medicine for Chronic Fatigue Syndrome through Longitudinal Large-Scale Multi-Modal Biological Omics Modeling with Machine Learning and Artificial Intelligence.

Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment.

Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment.

NOTIFICATION: Chronic Fatigue Syndrome.

NOTIFICATION: Chronic Fatigue Syndrome.

Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging.

Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging.

Chronic overlapping pain conditions in individuals with active opioid use disorder: a descriptive study of syringe program participants.

Chronic overlapping pain conditions in individuals with active opioid use disorder: a descriptive study of syringe program participants.

Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies.

Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies.

Protocol for a qualitative study on the online connections of people with ME/CFS and the relationship between these online connections and offline lives.

Protocol for a qualitative study on the online connections of people with ME/CFS and the relationship between these online connections and offline lives.

Co-occurrence of severe fatigue and insomnia: implications for the outcome of cognitive behavioural therapies.

Co-occurrence of severe fatigue and insomnia: implications for the outcome of cognitive behavioural therapies.

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.